Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Insmed Incorporated
IM8NCurrent price
65.5 EUR
0 EUR (0.00%)
Last closed
65.5 EUR
Company
www.insmed.com
ISIN
US4576693075
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
11 581 418 425 EUR
Yield for 12 month
+164.11 %
1Y
3Y
5Y
10Y
15Y
IM8N
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
46.54 EURP/E ratio
–Dividend Yield
–Current Year
+274 329 801 EUR
Last Year
+220 534 886 EUR
Current Quarter
+81 200 212 EUR
Last Quarter
+67 861 590 EUR
Current Year
+215 390 887 EUR
Last Year
+170 986 038 EUR
Current Quarter
+62 357 161 EUR
Last Quarter
+52 170 732 EUR
Key Figures IM8N
1 year
3 years
5 years
10 years
EBITDA
-634 915 609 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.77 %
PEG Ratio
–
Return On Equity TTM
-1453.41 %
Wall Street Target Price
46.54 EUR
Revenue TTM
328 589 272 EUR
Book Value
0.23 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
17 %
Dividend Yield
–
Gross Profit TTM
190 222 900 EUR
Earnings per share
-4.88 EUR
Diluted Eps TTM
-4.88 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-244.27 %
Dividend Analytics IM8N
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IM8N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.03.2011
Dividend Date
–
Stock Valuation IM8N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
38.9551
Price Sales TTM
35.2459
Enterprise Value EBITDA
-5.7089
Price Book MRQ
326.129
Financials IM8N
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IM8N
For 52 weeks
20 EUR
72 EUR
50 Day MA
67.79 EUR
Shares Short Prior Month
–
200 Day MA
40.49 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart